Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
Por un escritor de hombre misterioso
Descripción
New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome1 World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology2 Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving patients’ quality of life2 (Gräfelfing/Munich, Germany) The world's largest OTC irritable bowel syndrome (IBS) trial comes up with remarkable results, which were recently published in the renowned medical journal The Lancet Gastroenterology & Hepatology. For the first time, leading German scientists around Prof. Dr. Peter Layer (Israelitic Hospital Hamburg) were able to prove the significant efficacy of a heat-inactivated bacterial strain on patients with IBS. Trial results show that B. bifidum HI-MIMBb75
Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
Laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D) - American Gastroenterological Association
Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review - ScienceDirect
Irritable Bowel Syndrome: Questions and Answers for Effective Care
Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review - ScienceDirect
Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation - Food & Function (RSC Publishing) DOI:10.1039/D0FO02855J
Microorganisms, Free Full-Text
Irritable Bowel Syndrome
Clinical Trials and Studies - IFFGD
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review, Gut Microbiome
de
por adulto (el precio varía según el tamaño del grupo)